Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:17 PM
Ignite Modification Date:
2025-12-24 @ 2:17 PM
NCT ID:
NCT00427895
Eligibility Criteria:
Inclusion Criteria:
* First Cohort: Healthy Male and female adults 60 to 64 years of age at time of enrollment.
* Second Cohort: Healthy Male and female adults 50 to 59 years of age at time of enrollment.
* Third Cohort: Healthy Male and female adults 18 to 49 years of age at time of enrollment.
Exclusion Criteria:
* Previous immunization with any licensed or experimental pneumococcal vaccine.
* Serious chronic disorders including metastatic malignancy, severe chronic obstructive pulmonary disease (COPD) requiring supplemental oxygen, end stage renal disease with or without dialysis, clinically unstable cardiac disease, or any other disorder which in the investigator's opinion precludes the subject from participating in the study.
* Known or suspected impairment of immunological function.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
64 Years
Study:
NCT00427895
Study Brief:
Protocol Section:
NCT00427895